Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.895 USD | +6.08% | +6.43% | +0.17% |
28/05 | Acasti Pharma Inc. to Attend BIO International Convention 2024 | CI |
12/02 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.17% | 2.72Cr | |
+42.60% | 75TCr | |
+32.34% | 60TCr | |
-5.74% | 36TCr | |
+17.79% | 33TCr | |
+3.37% | 28TCr | |
+16.47% | 24TCr | |
+9.26% | 21TCr | |
-5.07% | 21TCr | |
+6.74% | 16TCr |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Appoints Prashant Kohli as CEO; to Proceed with Phase 3 Clinical Safety Study for GTX-104 Post FDA Feedback